Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -6.43% vs 17.24% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -64.03% vs -1,637.50% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -241.18% vs -44.44% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -18.32% vs 27.18% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Hubei Goto Biopharm Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -6.43% vs 17.24% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 16.03% vs 12.48% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -64.03% vs -1,637.50% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -137.50% vs -304.26% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -241.18% vs -44.44% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -2,100.00% vs -90.08% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -18.32% vs 27.18% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 94.55% vs 89.66% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






